Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-018780

Chief Accounting Officer sold 494 shares at $0.70 ($343)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-20 Sale : show line 1 in the form −494 $0.70 $343 78,853 D
Open-market sales · 494 sh · avg $0.70 · $343
Loading xslF345X05/ownership.xml…